ASSESSMENT OF BCR-ABL1 TRANSCRIPT LEVELS BY DIGITAL PCR (DPCR) IN CML PATIENTS WHO ACHIEVED A DMR (MR4.0, MR4.5 AND MR5.0) WITH TKIS (IMATINIB OR NILOTINIB) AND MAINTAINED THEIR DMR AFTER THE DISCONTINUATION OF THE TREATMENT
HAEMATOLOGICA(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要